Zhang Yueming, Kong Fanxiao, Li Nan, Tao Lina, Zhai Jinghui, Ma Jie, Zhang Sixi
Department of Clinical Pharmacy, The First Hospital of Jilin University, Jilin, China.
State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Front Cell Dev Biol. 2025 Mar 5;13:1525294. doi: 10.3389/fcell.2025.1525294. eCollection 2025.
Ferroptosis is a novel form of cell death that uniquely requires iron and is characterized by iron accumulation, the generation of free radicals leading to oxidative stress, and the formation of lipid peroxides, which distinguish it from other forms of cell death. The regulation of ferroptosis is extremely complex and is closely associated with a spectrum of diseases. Sirtuin 1 (SIRT1), a NAD + -dependent histone deacetylase, has emerged as a pivotal epigenetic regulator with the potential to regulate ferroptosis through a wide array of genes intricately associated with lipid metabolism, iron homeostasis, glutathione biosynthesis, and redox homeostasis. This review provides a comprehensive overview of the specific mechanisms by which SIRT1 regulates ferroptosis and explores its potential therapeutic value in the context of multiple disease pathologies, highlighting the significance of SIRT1-mediated ferroptosis in treatment strategies.
铁死亡是一种新型细胞死亡形式,其独特之处在于需要铁,其特征为铁蓄积、导致氧化应激的自由基生成以及脂质过氧化物的形成,这些使其有别于其他形式的细胞死亡。铁死亡的调控极其复杂,且与一系列疾病密切相关。沉默调节蛋白1(SIRT1)是一种依赖烟酰胺腺嘌呤二核苷酸(NAD +)的组蛋白脱乙酰酶,已成为一种关键的表观遗传调节因子,有可能通过与脂质代谢、铁稳态、谷胱甘肽生物合成及氧化还原稳态复杂相关的众多基因来调节铁死亡。本综述全面概述了SIRT1调节铁死亡的具体机制,并在多种疾病病理背景下探讨了其潜在治疗价值,强调了SIRT1介导的铁死亡在治疗策略中的重要性。